Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Chemed Corp

Healthcare US CHE

441.597USD
9.26(2.14%)

Last update at 2026-06-05T20:10:00Z

Day Range

427.65443.16
LowHigh

52 Week Range

365.20581.11
LowHigh

Fundamentals

  • Previous Close 432.34
  • Market Cap5145.27M
  • Volume218769
  • P/E Ratio21.05
  • Dividend Yield0.57%
  • EBITDA404.40M
  • Revenue TTM2529.98M
  • Revenue Per Share TTM175.72
  • Gross Profit TTM 823.18M
  • Diluted EPS TTM17.76

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 355.78M 399.46M 350.37M 329.68M 350.31M
Minority interest - - - - -
Net income 265.24M 302.00M 272.51M 249.62M 268.55M
Selling general administrative 417.19M 424.36M 395.12M 358.73M 366.73M
Selling and marketing expenses - 73.15M 72.20M - -
Gross profit 758.34M 854.35M 798.82M 765.09M 769.80M
Reconciled depreciation 64.84M 63.05M 59.93M 59.17M 59.05M
Ebit 357.53M 401.25M 353.48M 343.50M 343.04M
Ebitda 422.37M 464.29M 414.34M 393.44M 411.23M
Depreciation and amortization 64.84M 63.05M 60.87M 49.94M 68.19M
Non operating income net other - - - - 9.14M
Operating income 338.25M 366.49M 340.57M 343.50M 343.04M
Other operating expenses 2191.73M 2064.79M 1923.85M 1791.47M 1796.22M
Interest expense 1.75M 1.78M 3.11M 4.58M 1.87M
Tax provision 90.54M 97.47M 72.59M 80.06M 81.76M
Interest income 8.74M 14.61M 2.93M 14.20M 6.82M
Net interest income 7.00M 12.83M -1.43700M -4.22900M -1.49100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 90.54M 97.47M 77.86M 80.06M 81.76M
Total revenue 2529.98M 2431.29M 2264.42M 2134.96M 2139.26M
Total operating expenses 417.19M 487.86M 458.25M 421.59M 426.76M
Cost of revenue 1771.63M 1576.94M 1465.60M 1369.88M 1369.46M
Total other income expense net 17.53M 32.97M 9.80M -13.81700M 7.28M
Discontinued operations - - - - -
Net income from continuing ops 265.24M 302.00M 244.58M 249.62M 268.55M
Net income applicable to common shares 265.24M 302.00M 272.51M 249.62M 268.55M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1640.01M 1668.58M 1668.10M 1442.01M 1342.72M
Intangible assets 82.76M 92.21M 90.26M 99.73M 108.10M
Earning assets - - - - -
Other current assets 37.98M 37.04M 43.37M 48.81M 50.06M
Total liab 660.61M 549.58M 560.22M 643.30M 719.45M
Total stockholder equity 979.40M 1118.99M 1107.88M 798.72M 623.27M
Deferred long term liab - - - 1.70M 121.78M
Other current liab 170.61M 191.65M 186.82M 172.71M 39.03M
Common stock 37.59M 37.42M 37.18M 36.80M 36.51M
Capital stock 37.59M 37.42M 37.18M 36.80M 36.51M
Retained earnings 2955.38M 2721.83M 2446.93M 2197.92M 1970.31M
Other liab - - - 143.08M 131.42M
Good will 667.00M 666.74M 585.02M 581.29M 578.59M
Other assets 8.65M -98.79000M 53.95M 57.98M 107.02M
Cash 74.52M 178.35M 263.96M 74.13M 32.90M
Cash and equivalents 74.52M 178.35M 263.96M 74.13M 32.90M
Total current liabilities 287.13M 285.69M 312.05M 297.20M 302.40M
Current deferred revenue - - 6.86M 38.61M 152.43M
Net debt 80.24M -37.50600M -108.84700M 172.88M 290.65M
Short term debt 51.89M 42.31M 54.34M 44.00M 37.91M
Short long term debt - - 15.70M 5.00M -
Short long term debt total 154.76M 140.84M 155.11M 247.01M 323.54M
Other stockholder equity -2015.92000M -1640.26100M -1376.23300M -1435.99900M -1383.55200M
Property plant equipment 336.81M 328.16M 330.23M 335.38M 318.73M
Total current assets 302.62M 394.75M 500.84M 272.61M 230.29M
Long term investments - - - - 98.88M
Net tangible assets - - - 108.79M -63.41400M
Short term investments - - - - -
Net receivables 182.57M 171.16M 181.51M 139.41M 137.22M
Long term debt - - 0.00000M 92.50M 185.00M
Inventory 7.54M 8.19M 12.00M 10.27M 10.11M
Accounts payable 53.46M 44.15M 64.03M 41.88M 73.02M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.35M 2.22M 2.08M - -
Additional paid in capital - - - - -
Common stock total equity - - - - 36.51M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - 1970.31M
Treasury stock - - - - -2430.09400M
Accumulated amortization - - - - -
Non currrent assets other 8.65M 186.72M 161.74M 153.00M 8.14M
Deferred long term asset charges - - - - -
Non current assets total 1337.39M 1273.83M 1167.25M 1169.40M 1112.44M
Capital lease obligations 143.76M 140.84M 139.41M 149.51M 138.54M
Long term debt total 0.00000M 0.00000M 0.00000M 92.50M 185.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -143.91100M -68.46000M -59.40200M -57.75700M
Change to liabilities - - - 15.34M 9.83M
Total cashflows from investing activities -59.34000M -143.91100M -60.64200M -59.40200M -57.75700M
Net borrowings 10.97M -15.74900M -81.75100M -99.38400M 196.88M
Total cash from financing activities -432.76700M -359.19400M -79.82500M -209.25300M -380.62000M
Change to operating activities - - - -45.26100M -4.78600M
Net income 265.24M 302.00M 272.51M 249.62M 268.55M
Change in cash -103.83500M -85.60800M 189.83M 41.23M -129.78000M
Begin period cash flow 178.35M 263.96M 74.13M 32.90M 162.68M
End period cash flow 74.52M 178.35M 263.96M 74.13M 32.90M
Total cash from operating activities 388.27M 417.50M 330.30M 309.89M 308.60M
Issuance of capital stock - - - - -
Depreciation 64.84M 63.05M 60.87M 59.17M 59.05M
Other cashflows from investing activities 3.68M 3.02M 0.21M -2.07700M 0.92M
Dividends paid 31.70M 27.09M 23.50M 22.02M 22.02M
Change to inventory 0.65M 3.83M -1.73200M -0.16200M -3.01400M
Change to account receivables -11.59600M 10.68M -41.48800M -2.41400M -8.43100M
Sale purchase of stock -431.50000M -361.38900M -67.69700M -114.51500M -576.04200M
Other cashflows from financing activities -7.69400M 45.04M 93.12M 236.53M -0.16500M
Change to netincome - - - 34.24M 7.49M
Capital expenditures 62.80M 49.53M 56.85M 57.33M 58.67M
Change receivables - - - - -8.43100M
Cash flows other operating - - - - -35.03500M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -129.78000M
Change in working capital 23.71M 8.13M -39.30700M -33.49000M -26.80000M
Stock based compensation 4.89M 32.03M 30.08M -0.01560M 31.42M
Other non cash items 35.54M 16.42M 14.18M 37.94M -7.84900M
Free cash flow 325.48M 367.97M 273.44M 252.56M 249.92M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CHE
Chemed Corp		 9.26 2.14% 441.60 21.05 15.82 2.03 5.12 2.01 12.04
HCA
HCA Healthcare, Inc.		 10.30 2.85% 372.13 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.04 0.37% 10.75 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 - -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Chemed Corp

2600 First Financial Center, Cincinnati, OH, United States, 45202-4726

Key Executives

Name Title Year Born
Mr. Kevin J. McNamara CEO, Pres & Director 1954
Mr. David P. Williams Exec. VP & CFO 1961
Mr. Michael D. Witzeman CPA, MBA VP & Controller 1971
Mr. Nicholas Michael Westfall Exec. VP 1979
Ms. Lisa A. Reinhard VP, Chief Admin. Officer & Assistant Sec. NA
Sherri Warner Director of Investor Relations NA
Mr. Brian C. Judkins VP, Sec. & Chief Legal Officer 1981
Mr. Thomas C. Hutton VP & Director 1951
Mr. Kevin J. McNamara CEO, President & Director 1955
Mr. Michael D. Witzeman CPA, MBA Executive VP, Controller, Principal Accounting Officer & CFO 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.